FdaApplication
NDA 020926
Identifiers
- fda_app_no: NDA020926
Properties
| Property | Value |
|---|---|
| applicant_name | GENZYME CORP |
| application_type | NDA |
| approval_date | 1998-10-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RENAGEL | SEVELAMER HYDROCHLORIDE | 403MG | CAPSULE;ORAL |
1 product